Doctor profile · Federal record
Dr. MICHELLE WALTERS, MD
Dermatology Physician (CMS: DERMATOLOGY) · Dermatology Physician · Dermatology Physician · TULSA, OK
- NPI 1477538585
- Accepts Medicare
- MIPS 88.0 / 100 · 2023
- 23 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2424 E 21ST ST STE 340
TULSA, OK 741141722
(918) 728-3100
fax (918) 728-3376 - Mailing address
-
3131 S ZUNIS AVE
TULSA, OK 741052232
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- September 29, 2022
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (3)
- Oklahoma #38685 · Indiana #01059900A · Virginia #0101252959
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477538585. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,770
Distinct HCPCS
10
Medicare allowed
$99,593
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 653 | 116 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 234 | 170 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 232 | 164 | $45 | |
17110 |
Destruction of skin growth, 1-14 growths | 143 | 114 | $104 | |
11102 |
Biopsy of related skin growth, first growth | 138 | 117 | $83 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 76 | 76 | $106 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 61 | 56 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 56 | 44 | $120 | |
11103 |
Biopsy of related skin growth, each additional growth | 53 | 31 | $47 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 39 | 39 | $68 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 240. This provider delivers 7.4× the peer median.Open Payments
Industry payments received
All-time total
$880
Transactions
43
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $328.50 | |
| ABBVIE INC. | 10 | $208.88 | |
| LEO Pharma Inc. | 3 | $69.62 | |
| Novartis Pharmaceuticals Corporation | 3 | $67.43 | |
| Dermavant Sciences, Inc. | 2 | $37.64 | |
| Lilly USA, LLC | 2 | $33.62 | |
| UCB, Inc. | 2 | $32.23 | |
| Arcutis Biotherapeutics, Inc. | 2 | $30.39 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23.31 | |
| Amgen Inc. | 1 | $22.65 | |
| Janssen Biotech, Inc. | 1 | $13.83 | |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $12.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
195
Patients
114
Total drug cost
$8,838
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 51 | 29 | $5,001 |
| Triamcinolone Acetonide | Generic | 43 | 36 | $645 |
| Ketoconazole | Generic | 36 | 22 | $962 |
| Doxycycline Hyclate | Generic | 15 | 12 | $269 |
| Mupirocin | Generic | 15 | 15 | $133 |
| Fluocinonide | Generic | 12 | 0 | $886 |
| Fluorouracil | Generic | 12 | 0 | $734 |
| Hydroxyzine Hcl | Generic | 11 | 0 | $208 |